Dr. med. univ. Eleen Rothschedl

Eleen Rothschedl began working at AIHTA as part of the “Horizon Scanning in Oncology” project in 2013. She has been working as a researcher at AIHTA since 2014, mainly in oncology, where she has been involved in prioritising new and emerging oncology drugs, conducting early assessments of new oncology medicines, and preparing monthly fact sheets to support decision-making by drug commissions and payers. Most recently, she has focused on preparing HTAs for the Austrian Appraisal Board as part of the AIHTA Appraisal Board Author Group.

After her studies at the Medical Universities of Graz and Vienna, she worked as a research associate at the Department of Obstetrics and Gynaecology at the Medical University of Vienna.